SKI Market

Indian Indices

Nifty

26,013.45 103.40
(0.40%)

Sensex

84,950.95 388.17
( 0.46%)

Bank Nifty

58,962.70 445.15
( 0.76%)

Nifty IT

36,375.20 73.95
( 0.20%)

Global Indices

Nasdaq

47,163.83 -314.39
(-0.66%)

Dow Jones

6,754.35 -4.14
(-0.06%)

Hang Seng

50,246.57 -129.96
(-0.26%)

Nikkei 225

9,695.49 -2.88
(-0.03%)

Forex

USD-INR

88.71 0.12
(0.13%)

EUR-INR

103.04 0.44
(0.43%)

GBP-INR

116.72 0.41
(0.35%)

JPY-INR

0.57 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

33.17

31521.26

EPS(TTM)

Face Value()

Div & Yield %

76.07

1.11

Back

Savani Financials reports standalone net loss of Rs 3.21 crore in the September 2025 quarter

Nov 13,2025

Net Loss of Savani Financials reported to Rs 3.21 crore in the quarter ended September 2025 as against net loss of Rs 1.26 crore during the previous quarter ended September 2024. Sales rose 350.68% to Rs 3.29 crore in the quarter ended September 2025 as against Rs 0.73 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	3.29	0.73	351
OPM %	-62.01	-164.38	-
PBDT	-3.15	-1.21	-160
PBT	-3.22	-1.26	-156
NP	-3.21	-1.26	-155

26,013.45 103.40 (0.40%)

84,950.95 388.17 ( 0.46%)

58,962.70 445.15 ( 0.76%)

36,375.20 73.95 ( 0.20%)

47,163.83 -314.39 (-0.66%)

6,754.35 -4.14 (-0.06%)

50,246.57 -129.96 (-0.26%)

9,695.49 -2.88 (-0.03%)

88.71 0.12 (0.13%)

103.04 0.44 (0.43%)

116.72 0.41 (0.35%)

0.57 0.00 (0.16%)